BBGI’s high yield looks secure but the trust continues to trade at a wide discount...by David Kimberley
IBT is well positioned to exploit the attractive valuations on offer in the biotech sector...by Jo Groves
Kepler Trust Intelligence will be hosting online sessions with fund managers and investors, examining a wide range of strategies and themes to meet the needs of a diversified portfolio
With a more positive outlook for the biotech sector, IBT has proved its credentials in picking the winners...
MCT's strong dividend growth and prospective rate cuts may result in the trust's discount tightening in the year ahead...
AIE's bumper 2023 looks on track to continue into 2024...